Is this your brand? Sign in to claim ownership.

Sign in to claim this brand

Helena Laboratories, Corp.

US

Last updated September 17, 2026

About

Helena Laboratories provides quality products and services to customers worldwide. Our products include electrophoresis analyzers and supplies, densitometers, hemostasis reagents and instruments, immunology and protein diagnostic systems, disposable laboratory plasticware, fecal occult blood test kits, and a wide range of additional laboratory solutions.

From the manufacturer's own website. Source

What Helena Laboratories, Corp. makes

Helena Laboratories manufactures in vitro diagnostic devices including protein electrophoresis kits and reagents, faecal occult blood test kits, platelet aggregation study reagents, coagulation analyzers, densitometry analyzers, and electrophoresis analyzers.

The company's products are classified as Class I and Class II medical devices and are listed in the FDA Unique Device Identification (UDI) registry. Helena Laboratories is based in the United States.

Written from this company's registered devices by an AI model, and not verified by a human reviewer.

Frequently asked questions

What medical devices does Helena Laboratories manufacture?

Helena Laboratories manufactures in vitro diagnostic devices including protein electrophoresis kits and reagents, faecal occult blood test kits, platelet aggregation study reagents, coagulation analyzers, densitometry analyzers, and electrophoresis analyzers.

Where is Helena Laboratories based?

Helena Laboratories is based in the United States, as indicated by the country information provided in the device data.

Which regulatory registries list Helena Laboratories' devices?

Helena Laboratories' devices are listed in the FDA Unique Device Identification (UDI) registry, as specified in the device data.

How are Helena Laboratories' devices classified?

Helena Laboratories' devices are classified as Class I and Class II medical devices, according to the device classification information provided.

AI-generated from registry data and not verified by a human reviewer.

Information

Country
US
Address
1530 Lindbergh Dr, BEAUMONT, TX, 77707
Email
—
Phone
—
PRRC Contact
—
EUDAMED SRN
—
FDA FEI Number
1618982
DUNS Number
—

Catalogue (662)

Page 11 of 14
DeviceModel / ReferenceRegistriesClassStatus
Rep Hemoglobin Ief Kits (cat. No. 3250) K931503
FDA 510(k)
Class IIActive
Spife Ld-12 Kit, Model 3338 K022455
FDA 510(k)
Class IIActive
Rep 3 Quto-Flur Cholesterol-30 K962914
FDA 510(k)
Class IActive
Permaclear Solution Cat. No. 4950 K861490
FDA 510(k)
Class IActive
Glycosylated Hemoglobin-Smc Column K802233
FDA 510(k)
Class IIActive
Rep Alkaline Hb-15 #3196, -8 #3197, -4 3198 K931465
FDA 510(k)
Class IIActive
Coloscreen V.p.i. K832864
FDA 510(k)
Class IIActive
Rep Hdl Electrophoresis Method K882368
FDA 510(k)
Class IActive
Helena Colocare K882799
FDA 510(k)
Class IIActive
Titan Gel Glyco-Heme System K832087
FDA 510(k)
Class IIActive
Rep Ultra Hdl, Vldl/Ldl Cholesterol System K904035
FDA 510(k)
Class IActive
Columnmate Beta-Thal Hba2 Control - Normal K923318
FDA 510(k)
Class IIActive
Rep Spe Plus (acid Blue) System, # 3173/3174/3175 K922024
FDA 510(k)
Class IActive
Specialty Assayed Control-2 K100103
FDA 510(k)
Class IIActive
Cascade 480(tm) Automated Coagulation Analy. 1430 K901380
FDA 510(k)
Class IIActive
Titan Gel Immunofix-9 Cat. No. 3051 And 3067 K931247
FDA 510(k)
Class IIActive
Rocket Reference Plasma, Cat. No. 5188, Modified K911777
FDA 510(k)
Class IIActive
Ab-Trol Coagulation Control K802232
FDA 510(k)
Class IIActive
Titan Gel Cpk/Ldh Isoenzyme Control K821981
FDA 510(k)
Class IActive
Fetal Maturity Test Procedure K790798
FDA 510(k)
Class IIActive
Titan Gel-Pc Glyco-Heme(tm) System K880698
FDA 510(k)
Class IIActive
Spife 2000/3000 Lipoprotein; Model# 3340, 3341, 3342, 3343 K013466
FDA 510(k)
Class IActive
Rep Ck Isoforms Kit Cat. No. 3081, 3082, 3083 K896170
FDA 510(k)
Class IIActive
Titan Gel Iso Dot Cpk Procedure K842755
FDA 510(k)
Class IIActive
Bio Sure Stain K832496
FDA 510(k)
Class IActive
Helena Biostrip Ph K830979
FDA 510(k)
Class IActive
Rep(tm) Ck-2 Stat Kit, Cat. No. 3074 K893007
FDA 510(k)
Class IIActive
Automated Electrophoresis System K803281
FDA 510(k)
Class IActive
Biostrip G K820594
FDA 510(k)
Class IIActive
V8 Sp Normal Control, Abnormal Control K131479
FDA 510(k)
Class IActive
Titan Gel Rep Cpk-12 Hv K874146
FDA 510(k)
Class IIActive
Helena Factor Ix Deficient Substrate K792475
FDA 510(k)
Class IIActive
Actalyke Qc Kit, Models Aqc-Hp And Aqc-Lp K061014
FDA 510(k)
Class IIActive
Titan Gel High Resolution Serum Protein K821688
FDA 510(k)
Class IActive
Cellulose Acetate-Citrate Agar Hemoglo K813395
FDA 510(k)
Class IIActive
Adp Reagent, Modified K952252
FDA 510(k)
Class IIActive
Labile Lysing Reagent K884315
FDA 510(k)
Class IIActive
Rep Cholesterol Profile Template-30, -16, -8; Rep Vis Cholesterol K980650
FDA 510(k)
Class IActive
Rep Alp-15, 8, & 4 Kits K912603
FDA 510(k)
Class IIActive
Hbf-Quiplate Methodology K780807
FDA 510(k)
Class IIActive
Adp Reagent K910800
FDA 510(k)
Class IIActive
Helena Biostrip P K830977
FDA 510(k)
Class IActive
Helena Factor Xi Deficient Substrate K792476
FDA 510(k)
Class IIActive
Alkaline Phosphatase Indolyl Blue Reagent K870890
FDA 510(k)
Class IIActive
Titan Gel Immunofix Kit, Cat. No. 3046 K900422
FDA 510(k)
Class IIActive
Helena Hemoglobin F Controls K810475
FDA 510(k)
Class IIActive
Chrom Z Chromogenic Assays K951943
FDA 510(k)
Class IIActive
Electrophoresis Data Center (edc) K860645
FDA 510(k)
Class IActive
Activat-Partial Thrombo-Plastin K830320
FDA 510(k)
Class IIActive
Coagulation Arp K790826
FDA 510(k)
Class IIActive

Related Companies

Authorised Representatives

No authorised representatives on record.

Importers

Not available yet.

Notified Bodies

Not available yet.

Authorities

Not available yet.

FDA Recalls (16)

Recalls reported by this firm to the FDA. Listed at company level — FDA recall records don't identify a specific catalogue device.

Helena Laboratories, Corp. has 16 recall records initiated between 2016-04-20 and 2023-05-02, with statuses recorded as open, classified, and terminated. The reasons for recall include issues such as enzyme activity not being in range, particulate matter or microbial growth in reagents, mislabeled internal components, assay range variations, variations in test results, positive control reactivity issues, cracked test tube caps, and missing wells in plates.

AI-generated summary of the recall records listed below. It describes what the records state and is not an assessment of this manufacturer.

DateRecall No.ClassStatusReason
May 2, 2023Z-1975-2023—open, classified

Packaging for a serrated blade applicator kit (12 Sample) may contain a serrated blade applicator (18 sample). This results in a characteristic pattern of missed or light samples on the gel, leading to incorrect or no result, or delay in result.

Apr 6, 2022Z-1244-2022—open, classified

Due to microbial growth causing interference with interpretation.

Jan 5, 2021Z-1108-2021—terminated

Intermittent potential for shorter than expected clot times.

Nov 9, 2020Z-0635-2021—open, classified

Due to complaints received associated with cracked/split test tube caps.

Aug 8, 2018Z-1950-2019—open, classified

The positive control on some tests of the lots did not appropriately react within the specified timeframe to verify the test was functioning correctly.

Aug 8, 2018Z-1949-2019—open, classified

The positive control on some tests of the lots did not appropriately react within the specified timeframe to verify the test was functioning correctly.

May 23, 2018Z-0536-2020—open, classified

Through an investigation, it has been determined that vials of Collagen packaged within the Collagen Reagent and Platelet Aggregation Kit may contain particulate matter or microbial growth.

May 23, 2018Z-0537-2020—open, classified

Through an investigation, it has been determined that vials of Collagen packaged within the Collagen Reagent and Platelet aggregation Kit, may contain particulate matter or microbial growth.

Feb 27, 2018Z-0297-2020—open, classified

Lots of gel kits contained a newer revision of the Customer Procedures instructions than intended. The incorrect inserts refer to updated parameters associated with new electrodes -- which have not yet been made available to users.

Dec 7, 2017Z-2761-2019—terminated

Some of the cards show occasional shorter clot times than the expected variation resulting in a potential false negative result on the screening assay.

Jul 21, 2017Z-0045-2020—terminated

The plates do not have wells punched for the controls in the patient 1 area.

Apr 4, 2017Z-0106-2019—terminated

Internal components of the Protein S ELISA Antigen Kit (Lot: 3-16-5292) were mislabeled. The Protein S Conjugate Solution is labeled as Substrate, and the Substrate is labeled as Protein S conjugate.

Feb 24, 2017Z-0561-2019—terminated

Due to some cards in this lot reported to have experienced variations in results, (verified by wave form), resulting in some cards with shorter or longer times than expected.

Nov 7, 2016Z-0529-2019—terminated

Due to a customer experiencing complaints on bone fraction of assay not being in range. The complaint: ~12% lower enzyme activity was noted.

Oct 14, 2016Z-2434-2019—terminated

Due to customer-experienced complaints on narrow assay range compared to prior lots and the user being out of assay range.

Apr 20, 2016Z-0594-2019—terminated

Due to some cards in this lot experiencing variations in wave form, resulting in some cards with shorter or longer times than expected